3Levers K J, Kluijtmans LA, Heil SG, et al. Cystathionine beta-synthase polymorphisms and hyperhomocysteinaemia: an association study[J].Eur J Hum Genet, 2003,11(1):23-29.
4Camp VM, Chipponl J, Faraj BA, et al. Radioenzymatic assay for direct measurement of plasma pyridoxal 5'-phosphate [J]. Clin Chem, 1983,29(4):642-644.
5Kery V, Bukovaskat G, Kraus JP, et al. Transsulfuration depends on heme in addition to pyridoxal 5'-phosphate[J]. J Biol Chem, 1994,269(41):25283-25288.
6Kery V, Elleder D, Greenberg DM, et al. δ-Aminolevulinate increase yield and heme saturation of human cystathionine β-synthase expressedin Eschefichia coli[J]. Arch Biolchem Biophys, 1995,316(1) :24-29.
7Kraus JP, Paekman S, Fowler B, et al. Purification and properties of cystathionine beta synthase from human liver[J]. J Biol Chem, 1978,253(18):6253-6258.
8Kashiwamata S, Greenberg DM. Studies on cystathionine synthase of rat liver properties of the highly purified enzyme[J]. Biochim Biophys Acta, 1970,212(3):488-500.
9Selhub J. Homocysteine metabolism[ J]. Annu Rev Nutr, 1999,19(1) :217-246.
10Kluijtmans LAJ, Boers GUJ, Stevens EMB, et al. Defective cystathionine β-synthase regulation by s-adenosylmethionine in a partially pyridoxine responsive homoeystinuria patient[J]. J Clin Invest, 1996,98(2) : 285-289.
二级参考文献6
1Dudnam NPB, Guo XW, Cordon RB, et al, Human homocyateine cataholism: three major Pathways and their relevance to development of arterial occlusive disease. J Nutr, 1996 128: 1295-1300.
2Steegers-Theunlssen RPM, Boers GHJ, Trijbels JMF,et al. Neural tube defects and derangement of eysteine metabolism. N Engl J Med. 1991. 324: 199.
3Fletcher O and Kessling AM. MTHFR association with ateriosclerotic vascular disease? Hum Genet : 1998,103:11-21.
4Botto LD and Mastrojacovo P. Exploring gene-gene interactions in the edology of neural tube defects, Chin Genet.1998.53.456-459.
5van der Put NMJ, Gabreels F, Stevens EMB. et al. A second common mutation in the methyJenetetrahydrofo late reductase genet an ndditional risk laetor for neural tube defects. Am 1 Hum Gene, 1998. 62 1044-1051.
4Makris M. Hyperhomocysteinemia and thrombosis [ J ]. Clin Lab Haematol ,2000,22(3 ) : 133-134.
5Jacobs BR, Sacco RL, Roberts JK, et al. Race-ethnicity and other environmental determinants of serum homocysteine in northern Manhattan [ J]. Stroke, 1998,29:227.
6Mazza A, Giugiano D, Motti C, et al. Glycemia, MTHFR genotype and low homocysteine in uncomplicated type 2 diabetic patients[ J]. Atherosclerosis,2000,149( 1 ) :223-224.
7Hofmann MA, Kohl B, Zumbach MS, et al. Hyperhomoeysteinemia and endothelial dysfuntion in IDDM [ J ]. Diabetes Care, 1997,20: 1880-1886.
8Bar-On H, Kidron M, Friedlander Y, et al. Plasma total homocysteine levels in subject with hyperinsulinemia [ J ]. Intern Med, 2000,247 (2) :287-294.
9Emoto M, Kanda H, Shoji T, et al. Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes[ J]. Diabetes Care, 2001,24(3 ) :533-538.
10EK Hoogeveen, PJ Kostense, C Jakobs, et al. Hyperhomocysteine increased risk of death, especially in type 2 diabetes [ J ]. Circulation, 2000,101 (13) :1506-1511.
